This study was designed to detect serum levels of miR-576-3p, miR-613, NDRG2 and YKL40 in colon cancer patients to estimate their diagnostic value which may help to understand their roles in the pathogenesis of CRC. This evidence concerns the gene CHI3L1 and colorectal carcinoma.